Shukra Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

44.80

10.29

14.54

5.95

2.78

Operating profit

5.42

1.43

4.62

-1.73

0.60

Interest

0.15

0.16

0.25

0.04

-

Gross profit

6.15

1.30

1.82

0.86

0.84

EPS (Rs)

4.68

2.58

4.44

0.36

0.71

Other income

0.88

0.04

-2.55

2.63

0.24

Stock adjustment

1.79

-0.55

0.05

-0.79

-0.68

Raw material

6.82

6.06

6.87

4.21

0.42

Power and fuel

-

-

-

-

-

Employee expenses

2.72

2.50

2.73

2.17

1.49

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

28.05

0.85

0.26

2.09

0.96

Provisions made

-

-

-

-

-

Depreciation

1.02

0.87

0.93

0.74

0.72

Taxation

-

0.03

0.20

0.07

-

Net profit / loss

5.13

0.40

0.69

0.06

0.11

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.96

1.57

1.57

1.57

1.57

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

12.11

13.87

31.75

-29.11

21.53

GPM (%)

13.47

12.64

15.19

10.01

27.62

NPM (%)

11.23

3.92

5.79

0.66

3.67